
KIVOTEL AM is an antihypertensive combination medicine containing Telmisartan and Amlodipine, marketed by Kivonyx Healthcare Pvt. Ltd. It is prescribed for managing high blood pressure (hypertension) in patients requiring dual therapy. Telmisartan is an angiotensin II receptor blocker (ARB), while Amlodipine is a calcium channel blocker. Together, these ingredients help relax blood vessels, improve blood flow, and maintain controlled blood pressure. KIVOTEL AM is available in convenient 10 × 10 tablet packaging, making it suitable for pharmaceutical distributors, healthcare professionals, and medical suppliers. This cardiovascular medicine is part of Kivonyx Healthcare's cardiac and diabetic product range. Patients should use KIVOTEL AM strictly according to a qualified healthcare professional's prescription.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Kivonyx Healthcare Pvt. Ltd. is a leading pharmaceutical company in Ahmedabad, with a primary focus on providing high-quality healthcare products to its clients and customers that cater to a diverse range of health disorders. We are deeply committed to offering innovative healthcare solutions that improve patients’ health and enhance their quality of life. In everything we do or engage with, the foundation remains the same; i.e. an unwavering dedication to quality and innovation.
All our products are manufactured in WHO GMP-certified facilities. With the backing of a strong network, our product range reaches the entire nation with a well-structured distribution channel. Thus, we are highly reliable as a brand when it comes to taking care of the ever-evolving needs of the healthcare community. We offer a wide range of pharmaceutical products for improving patient care, ranging from antibiotics and antifungal treatments to advanced vitamin supplements.
We believe in continuous improvement through research and development, enabling us to stay at the forefront of medical advancements. By combining state-of-the-art technology with a patient-centric approach, we ensure that our solutions not only meet but exceed the expectations of the healthcare sector.